TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Benchmark Genetics Norway AS
Closing information (x1000 SEK)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
422,942
|
371,145
|
291,704 |
Financial expenses |
6,059
|
6,082
|
5,136 |
Earnings before taxes |
55,214
|
42,462
|
19,438 |
Total assets |
328,299
|
340,206
|
327,557 |
Current assets |
90,100
|
99,287
|
98,539 |
Current liabilities |
101,499
|
85,188
|
57,146 |
Equity capital |
159,387
|
119,035
|
82,116 |
- share capital |
9,181
|
9,387
|
9,008 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
48.5%
|
35.0%
|
25.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.1%
|
11.4%
|
6.7% |
Return on assets (ROA) |
18.7%
|
14.3%
|
7.5% |
Current ratio |
88.8%
|
116.6%
|
172.4% |
Return on equity (ROE) |
34.6%
|
35.7%
|
23.7% |
Change turnover |
59,938
|
67,155
|
52,439 |
Change turnover % |
17%
|
22%
![]() |
22% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.